logo

For the Inventor, By the Inventor

Gujarat, India

Bipin Pandey

USPTO Granted Patents = 18 


 

Average Co-Inventor Count = 3.1

ph-index = 4

Forward Citations = 40(Granted Patents)


Location History:

  • Ahmedabad, IN (2013 - 2016)
  • Gujarat, IN (2003 - 2018)

Company Filing History:

goldMedal18 out of 130 
 
Cadila Healthcare Limited
 patents

Years Active: 2003-2018

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents
1. 10017470 - Treatment for lipodystrophy (2018-07-10),
2. 9783495 - Treatment for lipodystrophy (2017-10-10),
3. 9242926 - Processes for the preparation of lacosamide and intermediates thereof (2016-01-26),
4. 9108972 - Salts of DPP-IV inhibitor (2015-08-18),
5. 8993773 - Process to prepare pioglitazone via several novel intermediates (2015-03-31),
6. 8962832 - Process for the preparation of ambrisentan and novel intermediates thereof (2015-02-24),
7. 8907090 - Processes for preparing different forms of (S)-(+)-Clopidogrel bisulfate (2014-12-09),
8. 8853439 - Processes for the preparation of lacosamide and intermediates thereof (2014-10-07),
9. 8754207 - Process for the preparation of rapamycin derivatives (2014-06-17),
10. 8476437 - Process for preparation of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine and new impurities in preparation thereof (2013-07-02),
11. 8445685 - Process to prepare pioglitazone via several novel intermediates (2013-05-21),
12. 8173816 - Process to prepare pioglitazone via several novel intermediates (2012-05-08),
13. 7994322 - Processes for the preparation of different forms of (S)-(+)-clopidogrel besylate (2011-08-09),
14. 7872019 - Polymorphs and amorphous form of (S)-(+)-clopidogrel bisulfate (2011-01-18),
15. 7863300 - Process to prepare pioglitazone via several novel intermediates (2011-01-04),

Title: Innovating Healthcare: The Contributions of Bipin Pandey

Introduction: Bipin Pandey, an accomplished inventor based in Gujarat, India, has made significant strides in the field of therapeutic advancements. With a remarkable portfolio of 18 patents, he continues to push the boundaries of innovation, particularly in the treatment of medical conditions associated with HIV.

Latest Patents: Among his latest contributions is a groundbreaking invention aimed at treating lipodystrophy. This innovative therapeutic compound, represented by formula (I) and its pharmaceutically acceptable salts, is designed to prevent and treat lipodystrophy resulting from HIV infection or combination therapies involving HIV-1 protease inhibitors (PIs) and/or reverse transcriptase inhibitors (nRTIs). The focus of this invention lies in neutralizing lipohypertrophy, lipoatrophy, and metabolic abnormalities in HIV patients, thereby improving their quality of life.

Career Highlights: Bipin's career has been marked by his tenure at Cadila Healthcare Limited, a leading company in the pharmaceutical sector. His dedication to research and development has resulted in valuable patents that contribute not only to the company’s portfolio but also to global healthcare solutions.

Collaborations: Bipin collaborates closely with talented professionals such as Braj Bhushan Lohray and Vidya Bhushan Lohray, harnessing their collective expertise to drive innovation within the company. These collaborations facilitate the development of new treatments and enhance the research endeavors at Cadila Healthcare.

Conclusion: Bipin Pandey's contributions to medical innovation exemplify the vital role of inventors in advancing healthcare. As he continues to develop new solutions for pressing medical issues, his work remains pivotal in transforming the landscape of therapeutic treatments. Through his patents and collaborations, Bipin is making a significant impact on the lives of many, particularly within the HIV community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…